EP Patent

EP4218730B1 — Liposomes useful for drug delivery

Assigned to Ipsen Biopharm Ltd · Expires 2023-11-01 · 3y expired

What this patent protects

Patent listed against Camptosar.

Drugs covered by this patent

Camptosar (Irinotecan Hydrochloride) · Pfizer

Patent Metadata

Patent number: EP4218730B1
Jurisdiction: EP
Classification: —
Expires: 2023-11-01
Drug substance claim: No
Drug product claim: No
Assignee: Ipsen Biopharm Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.